agilon health’s (AGL) Outperform Rating Reaffirmed at Royal Bank of Canada

Royal Bank of Canada reaffirmed their outperform rating on shares of agilon health (NYSE:AGL) in a research report released on Tuesday,Benzinga reports. They currently have a $3.00 target price on the stock.

Other analysts have also recently issued research reports about the stock. Bank of America cut shares of agilon health from a “buy” rating to an “underperform” rating and set a $3.00 target price for the company. in a research report on Wednesday, October 2nd. Benchmark reissued a “buy” rating and issued a $9.00 price target on shares of agilon health in a report on Thursday, August 8th. William Blair lowered shares of agilon health from an “outperform” rating to a “market perform” rating in a report on Friday, November 8th. Deutsche Bank Aktiengesellschaft decreased their price target on shares of agilon health from $5.00 to $4.00 and set a “hold” rating for the company in a report on Friday, August 9th. Finally, Citigroup decreased their price target on shares of agilon health from $2.50 to $1.75 and set a “sell” rating for the company in a report on Wednesday, November 13th. Three research analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $6.05.

agilon health Stock Performance

Shares of agilon health stock opened at $1.59 on Tuesday. The firm has a fifty day moving average of $2.97 and a two-hundred day moving average of $4.81. The stock has a market capitalization of $655.11 million, a price-to-earnings ratio of -1.69 and a beta of 0.60. agilon health has a 52 week low of $1.50 and a 52 week high of $13.76. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29.

agilon health (NYSE:AGL) last issued its earnings results on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.19). The business had revenue of $1.45 billion for the quarter, compared to the consensus estimate of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. During the same quarter in the previous year, the firm posted ($0.06) EPS. As a group, equities research analysts predict that agilon health will post -0.47 EPS for the current year.

Insider Transactions at agilon health

In other agilon health news, CEO Steven Sell acquired 20,000 shares of agilon health stock in a transaction dated Thursday, September 12th. The stock was bought at an average cost of $3.36 per share, for a total transaction of $67,200.00. Following the purchase, the chief executive officer now directly owns 67,590 shares in the company, valued at approximately $227,102.40. This represents a 42.03 % increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. Company insiders own 3.20% of the company’s stock.

Hedge Funds Weigh In On agilon health

A number of large investors have recently modified their holdings of AGL. Capital International Investors boosted its stake in shares of agilon health by 84.7% during the 1st quarter. Capital International Investors now owns 20,197,932 shares of the company’s stock worth $123,207,000 after buying an additional 9,263,296 shares during the last quarter. Citigroup Inc. raised its holdings in shares of agilon health by 2,251.5% in the 3rd quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock valued at $7,971,000 after purchasing an additional 1,941,993 shares during the period. AQR Capital Management LLC raised its holdings in shares of agilon health by 3,338.5% in the 2nd quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock valued at $8,871,000 after purchasing an additional 1,316,990 shares during the period. Quantbot Technologies LP bought a new stake in shares of agilon health in the 3rd quarter valued at about $1,742,000. Finally, Vanguard Group Inc. raised its holdings in shares of agilon health by 1.3% in the 1st quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company’s stock valued at $176,582,000 after purchasing an additional 371,537 shares during the period.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.